Clinical Trials

486 enrolled

CNS

Glioblastoma

NCT05941741 2026-03-18

IC Plus Low-dose Radiation Plus Cadonilimab in LANPC

380 enrolled

Nasopharyngeal Carcinoma

NCT06377852 2026-03-18

The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study

500 enrolled

Breast Neoplasms

NCT02064673 2026-03-17

Adjuvant Curcumin to Assess Recurrence Free Survival in Patients Who Have Had a Radical Prostatectomy

608 enrolled

Prostatic Neoplasms

NCT05738694 2026-03-17

Neoadjuvant of Axitinib Plus PD-1 to Improve Disease Free Survival of Patients With Renal Cell Carcinoma

298 enrolled

Carcinoma, Renal Cell

NCT07396480 2026-03-17

Fludarabine Plus Melphalan Versus Addition of Venetoclax to Fludarabine/Melphalan Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation in AML/MDS Patients Aged > 50 Years: a Multicenter, Randomized, Phase 3 Trial

186 enrolled

Other neoplasm

Venentoclax

NCT04628026 2026-03-16

Phase III Study of Induction and Consolidation Chemotherapy With Venetoclax in Patients With Newly Diagnosed AML or MDS-EB-2

Other hematologic neoplasm

650 enrolled

Leukemia, Myeloid, Acute

NCT07237256 2026-03-16

NoLEEta

3,902 enrolled

Breast Neoplasms

NCT07459296 2026-03-16

Becotatug Vedotin Plus Sintilimab in Locoregionally Advanced NPC

266 enrolled

Nasopharyngeal Carcinoma

NCT07463235 2026-03-13

SPARAGMOS

70 enrolled

Hyperprolactinemia, Prolactinoma

NCT06626022 2026-03-12

MUSIC-Screen

1,284 enrolled

Prostate Cancer Screening

NCT07100990 2026-03-11

TIMELY-PLEX

382 enrolled

Myelitis, Myelitis, Transverse, Optic Neuritis

NCT05871099 2026-03-06

Laparoscopic Gastrectomy With D2 Lymphadenectomy Combined With Hyperthermic Intraperitoneal Chemotherapy (HIPEC) or Not

616 enrolled

Stomach Neoplasms

NCT05918302 2026-03-06

LEVEL

120 enrolled

EndocrineNET

Thymus Neoplasms, Neuroendocrine Tumors

NCT06239727 2026-03-06

Reduced-dose Radiotherapy for Stage III Nasopharyngeal Carcinoma Based on the Treatment Response

593 enrolled

Nasopharyngeal Carcinoma

NCT04230187 2026-03-05

TRIBE-C

528 enrolled

Colorectal Neoplasms

NCT04575935 2026-03-05

Minimally Invasive Surgery After Neoadjuvant Chemotherapy for the Treatment of Stage IIIC-IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer, LANCE Trial

580 enrolled

Gynecologic

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT07083154 2026-03-05

GLP-1/GCG Dual Agonist in Type 2 Diabetes With Early Dementia (LIGHT-COG Study)

420 enrolled

Lymphoid

Dementia, Diabetes Mellitus, Type 2, Lymphoma, Follicular, Cognitive Dysfunction

NCT04939090 2026-03-04

Olanzapine Versus Megestrol Acetate for the Treatment of Loss of Appetite Among Advanced Cancer Patients

Other hematologic neoplasm

360 enrolled

Anorexia, Hematologic Neoplasms

NCT05008848 2026-03-04

Reaching Rural Cancer Survivors Who Smoke Using Text-Based Program

600 enrolled

Cigarette Smoking-Related Carcinoma

NCT05673148 2026-03-04

Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, The ERASur Study

364 enrolled

Colorectal Neoplasms

NCT05677490 2026-03-04

mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma

382 enrolled

Adenocarcinoma Of Esophagus

NCT05812807 2026-03-04

Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab

1,295 enrolled

Anatomic Stage I Breast Cancer AJCC v8

NCT05976763 2026-03-04

Testing Continuous Versus Intermittent Treatment With the Study Drug Zanubrutinib for Older Patients With Previously Untreated Mantle Cell Lymphoma

421 enrolled

Lymphoid

Lymphoma, Mantle-Cell

NCT06632327 2026-03-04

Comparing Impact of Treatment Before or After Surgery in Patients With Stage II-IIIB Resectable Non-small Cell Lung Cancer

1,100 enrolled

Thoracic

Lung Neoplasms

NCT06661720 2026-03-04

STRIKE

1,040 enrolled

Carcinoma, Renal Cell

NCT06931340 2026-03-04

Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial

1,260 enrolled

Prostatic Neoplasms

NCT06992427 2026-03-04

HOPE

228 enrolled

Squamous Cell Carcinoma of Head and Neck

NCT07000084 2026-03-04

GAIN-BCG

330 enrolled

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms

NCT07327216 2026-03-04

Sapylin Versus Dexamethasone Inhalation for CCRT-Induced Oral Mucositis in Nasopharyngeal Carcinoma

180 enrolled

Nasopharyngeal Carcinoma

NCT04215731 2026-03-03

FOBEAR

582 enrolled

Rectal Neoplasms

NCT04852887 2026-03-03

DEBRA

1,670 enrolled

Breast Neoplasms

NCT05879926 2026-03-03

OFSET

3,960 enrolled

Breast Neoplasms

NCT06748222 2026-03-03

HEAL-ABC

402 enrolled

Breast Neoplasms, Depression

NCT06798922 2026-03-03

OPTIFLAP

348 enrolled

Mouth Neoplasms

NCT06346197 2026-03-02

CIME

132 enrolled

Neoplasm Metastasis, Stomach Neoplasms

NCT07026474 2026-03-02

RePaIr-HN

214 enrolled

Squamous Cell Carcinoma of Head and Neck

NCT07132684 2026-03-02

Comparison of VA and D/IA Induction Regimens in Elderly Fit Acute Myeloid Leukemia Patients

Other hematologic neoplasm

240 enrolled

Leukemia, Myeloid, Acute

NCT07443397 2026-03-02

Anlotinib Plus Whole-Brain Radiotherapy for Brain Metastases in SCLC Patients.

134 enrolled

Whole-Brain Radiotherapy

NCT05417516 2026-02-27

A Randomized Trial of Five Fraction Partial Breast Irradiation (RAPID2)

910 enrolled

Breast Neoplasm Female

NCT06554652 2026-02-27

Selective Neck Dissection Versus Modified Neck Dissection in PTC

250 enrolled

Thyroid Neoplasms

NCT06558981 2026-02-27

Adjuvant Radiotherapy in High Risk Locally Advanced DTC

124 enrolled

Thyroid Neoplasms

NCT07281833 2026-02-27

CAPIcorn

250 enrolled

Breast Neoplasms, Neoplasm Metastasis, Disease Progression

NCT07441291 2026-02-27

CD19 CAR-T vs DLI for Post-HSCT MRD in Ph- ALL: A RCT

70 enrolled

Tumor-Agnostic

Neoplasm, Residual

NCT05581121 2026-02-25

PAROLA

510 enrolled

Gynecologic

Adenocarcinoma, Uterine Cervical Neoplasms, Carcinoma, Adenosquamous

NCT06888817 2026-02-25

BRAINS

408 enrolled

CNS

Brain Neoplasms, Glioma, Radiation Injuries

NCT06507618 2026-02-24

POWER II

354 enrolled

Breast Neoplasms

NCT07414758 2026-02-24

T-START-M1

68 enrolled

Lymphoid

Lymphoma, T-Cell, Peripheral

NCT07215949 2026-02-23

Zilucoplan for Severe gMG Exacerbations